Thermo Fisher Scientific Inc. (TMO)
| Market Cap | 200.45B |
| Revenue (ttm) | 42.37B |
| Net Income (ttm) | 6.14B |
| Shares Out | 382.50M |
| EPS (ttm) | 15.95 |
| PE Ratio | 32.85 |
| Forward PE | 23.04 |
| Dividend | $1.56 (0.30%) |
| Ex-Dividend Date | Dec 13, 2024 |
| Volume | 1,417,719 |
| Open | 516.69 |
| Previous Close | 516.69 |
| Day's Range | 515.00 - 526.43 |
| 52-Week Range | 493.30 - 627.88 |
| Beta | 0.77 |
| Analysts | Strong Buy |
| Price Target | 650.72 (+24.17%) |
| Earnings Date | Jan 29, 2025 |
About TMO
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company’s Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechno... [Read more]
Financial Performance
In 2023, Thermo Fisher's revenue was $42.86 billion, a decrease of -4.58% compared to the previous year's $44.92 billion. Earnings were $6.00 billion, a decrease of -13.74%.
Financial StatementsAnalyst Forecast
According to 18 analysts, the average rating for TMO stock is "Strong Buy." The 12-month stock price forecast is $650.72, which is an increase of 24.17% from the latest price.
News
Knipper Health Announces Transfer of Commercial Sample Management Business from Thermo Fisher Scientific
LAKEWOOD, N.J.--(BUSINESS WIRE)--Knipper Health, Inc., the largest supplier of end-to-end pharmaceutical healthcare marketing services and solutions in the U.S. serving the biopharmaceutical and medic...
Thermo Fisher: The Cycle Has Already Turned Around
Thermo Fisher's stock is now a "buy" due to signs of recovery, including positive sales growth and stabilized margins, despite recent bearish trends. The company's post-pandemic challenges are easing,...
Thermo Fisher Scientific: Renewed Growth Momentum After The Pandemic
Thermo Fisher Scientific is well-positioned for growth due to its consistent revenue streams, strong M&A track record and minimal macroeconomic dependence. Despite a COVID-related revenue surge and su...
Thermo Fisher: M&A And Innovation To Drive Sales Growth
The reduction in revenues due to the decline in COVID-19-related products and services is expected to diminish or disappear in 2025. Thermo Fisher has been growing by acquiring other companies. This s...
Thermo Fisher Scientific Launches CTS Detachable Dynabeads CD4 and CTS Detachable Dynabeads CD8 to Enhance Cell Therapy Development and Production
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, today unveiled the Gibco™ CTS™ Detachable Dynabeads™ CD4 and CTS Detachable Dynabeads CD8 (CTS Deta...
Thermo Fisher Scientific Completes $1B Share Repurchase
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that it has completed the repurchase of $1 billion (1.9 million shares)...
Mainz Biomed Announces Reverse Stock Split Soon After Collaborating With MedTech Giant Thermo Fisher Scientific
Mainz Biomed N.V. MYNZ announced a 1-for-40 reverse stock split, effective Dec. 3.
Thermo Fisher Scientific Inc. (TMO) Wolfe 2024 Healthcare Conference (Transcript)
Thermo Fisher Scientific Inc. (NYSE:TMO) Wolfe 2024 Healthcare Results Conference November 19, 2024 8:00 AM ET Company Participants Marc Casper - Chairman, President and Chief Executive Officer Confe...
Thermo Fisher Scientific Authorizes $4 Billion of Share Repurchases
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its Board of Directors has authorized the repurchase of $4 billion...
Thermo Fisher Scientific: Near The Bottom And Attractively Valued
Thermo Fisher Scientific has strong growth prospects due to easing COVID-19 headwinds, improving Chinese and biotech markets, and favorable funding environments. The company's margins should benefit f...
Thermo Fisher Scientific to Present at the Wolfe 2024 Healthcare Conference on November 19, 2024
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, chairman, president and chief executive officer, will pr...
Thermo Fisher Scientific Declares Quarterly Dividend
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its Board of Directors authorized a quarterly cash dividend of $0....
Thermo Fisher Scientific Inc. (TMO) Q3 2024 Earnings Call Transcript
Thermo Fisher Scientific Inc. (NYSE:TMO) Q3 2024 Earnings Conference Call October 23, 2024 8:30 AM ET Company Participants Rafael Tejada - Vice President, Investor Relations Marc Casper - Chairman, P...
Thermo Fisher Scientific Q3: Expecting Market Recovery In FY25; Upgrade To 'Buy'
I am upgrading Thermo Fisher Scientific Inc. to a “Buy” with a fair value of $610 per share due to anticipated recovery in the pharma and biotech industries. Thermo Fisher's high-impact innovations an...
Thermo Fisher raises profit forecast on strong demand for its tools and services
Thermo Fisher Scientific on Wednesday raised the lower end of its annual profit forecast, tweaking it for the third time this year, betting on improved demand for its tools and services used in drug d...
Thermo Fisher Scientific Reports Third Quarter 2024 Results
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the third quarter ended September 28, 2024. Th...
Lab Consumables Business Research Report 2024-2030 with Focus on 350+ Select Players Including Thermo Fisher Scientific, VITLAB, Bellco Glass, Eppendorf and BRAND Scientific Equipment Among Others
Dublin, Oct. 22, 2024 (GLOBE NEWSWIRE) -- The "Lab Consumables - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. The global market for Lab Consumables is ...
Thermo Fisher Scientific Introduces Fully Integrated Multimodal Analytical Scanning Transmission Electron Microscope to Advance Novel Research in Materials Science
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, introduced a groundbreaking transmission electron microscope to a packed room of attendees at the r...
Thermo Fisher Scientific Introduces Ambient Shipping Solution for its Invitrogen™ Antibodies to Help Customers Reduce Packaging Waste and Carbon Emissions
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, today introduced more sustainable packaging for 125,000 of its Invitrogen™ antibodies. Transitionin...
Thermo Fisher Scientific Showcases Expanded Biopharma Services, Capabilities and Innovations at CPHI Milan 2024
MILAN--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, will showcase its latest innovations enabling the molecule-to-medicine journey and host a series of sessions...
Thermo Fisher Scientific: Fantastic Company, Rich Valuation
Thermo Fisher has outperformed the market with a 420%+ return over the past decade, but its current valuation is high. The company's recent results show mixed performance, with slight revenue decline,...
Exclusive: Thermo Fisher's plant making infant RSV drug breached FDA rules, documents show
One of the largest contract drug manufacturing plants in the U.S. owned by Thermo Fisher Scientific over the past 10 years has repeatedly breached rules meant to ensure drugs are free of contamination...
Industry Leader Thermo Fisher's Contract Services Positioned For Growth Amid Popular Demand For GLP-1 Weight Loss Drugs, Analyst Initiates With Long-Term Growth Potential
Stephens initiated coverage on Thermo Fisher Scientific TMO and cited the company as an industry leader in the broader life science tools/services/ diagnostics industry, with fiscal year 2023 sales of...
Calls of the Day: General Motors, GE Healthcare, Thermo Fisher, HealthEquity, Carmax and SharkNinja
The Investment Committee debate the latest Calls Of The Day and Jim Lebenthal responds to Sarat Sethi selling out of General Motors
Thermo Fisher Scientific Introduces Mass Spectrometers to Simplify Trace Elemental Analysis and Enhance Productivity
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. today launched the Thermo Scientific™ iCAP™ MX Series ICP-MS to simplify trace element analysis with inductively coupled plasma mass spec...